| Literature DB >> 27374986 |
Lauren E Walker1, Damir Janigro2, Uwe Heinemann3, Raili Riikonen4, Christophe Bernard5, Manisha Patel6.
Abstract
Peripheral biomarkers have myriad potential uses for treatment, prediction, prognostication, and pharmacovigilance in epilepsy. To date, no single peripheral biomarker has demonstrated proven effectiveness, although multiple candidates are in development. In this review, we discuss the major areas of focus including inflammation, blood-brain barrier dysfunction, redox alterations, metabolism, hormones and growth factors. Wiley Periodicals, Inc.Entities:
Keywords: Blood-brain barrier; High mobility group box 1 (HMGB1); Inflammation; Insulin-like growth factor; S100B; brain derived neurotrophic factor
Mesh:
Substances:
Year: 2016 PMID: 27374986 PMCID: PMC5515385 DOI: 10.1111/epi.13460
Source DB: PubMed Journal: Epilepsia ISSN: 0013-9580 Impact factor: 5.864